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Analytical techniques based on Ultraviolet (UV) spectrophotometry are widely used in pharmaceutical analysis, because 
they are simple and inexpensive. The choice of pH is critical in the development of univariate methods for pharmaceutical 
quantitation by UV spectrophotometry since changes may modify the absorption spectrum profile. Similar to univariate 
methods by UV spectrophotometry changes in pH may influence the predictive ability of multivariate models, affecting 
the resultant analytical performance. We report herein on the influence of pH on the simultaneous determination of 
sulfamethoxazole (SMZ) and trimethoprim (TMP) in tablets using UV spectrophotometry and multivariate calibration. 
Data were recorded using a UV spectrophotometer in the wavelength range of 200 to 350 nm. The experimental matrix 
was constructed using 36 synthetic samples of SMZ-TMP mixtures. The concentration ranges used for the investigation 
were 14.0 to 26.0 mg L-1 for SMZ and 2.8 to 5.2 mg L-1 for TMP. The Partial Least Squares (PLS) regression models were 
generated with full-spectrum and multiple pH levels. At pH 4.3, lower values of relative standard error of prediction (RSEP 
%) for SMZ (1.83) and TMP (1.13) were obtained. The PLS model at pH 4.3 was used for the quantification of real samples 
(tablets obtained from 13 different manufacturers) and the results were compared with conventional procedures using high 
performance liquid chromatography (HPLC).  
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Introduction 
 
Sulfamethoxazole (SMZ) is a synthetic 
antibacterial drug belonging to the 
sulfonamides, which is similar in structure to p-
aminobenzoic acid, and inhibits the 
incorporation of p-aminobenzoic acid into folic 
acid. Association of SMZ with trimethoprim 
(TMP) results in a synergistic effect, since TMP 
acts via inhibition of dihydrofolate reductase 
(1). This synergistic effect induces potent 
antimicrobial activity because SMZ-TMP acts 
on different stages of bacterial DNA synthesis. 
Pharmaceutical formulations containing SMZ-
TMP are commercially available in tablet form 
and in parenteral solutions. The chemical 
structures of SMZ (A) and TMP (B) are showed 
in Figure 1.  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Chemical structure of SMZ (A) and TMP (B) 
 
Official monographs for SMZ-TMP 
quantification in pharmaceutical preparation 
have been described using high performance 
liquid chromatography (HPLC) and 
spectrophotometric methods, which involve 
pre-separation of the analytes under 
investigation (2,3). Several other methods have 
also been reported for SMZ-TMP 
determination based on: (a) complexation 
reactions/spectrophotometric analysis (4), first 
derivative spectrophotometric analysis (5), 
bivariate calibration (6) and multivariate 
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calibration (7–9).These alternative methods 
could replace those based on HPLC since they 
are faster and comparatively inexpensive (10–
14). Nevertheless, alternative methods using 
ultraviolet (UV) spectrophotometric techniques 
require multivariate data processing due to 
spectral overlap and pH adjustment due to a 
shift in the lambda maximum. 
Multivariate data processing using partial 
least squares (PLS) regression models has been 
used in association with UV 
spectrophotometric methods for the 
simultaneous determination of pharmaceutical 
formulations, especially in cases of spectral 
overlap resolution (15–18). However, for 
spectroscopic data produced by multivariate 
regression analysis, few studies have been 
reported that evaluate pH changes that may 
exert significant influence on PLS models, 
mainly because of possible protonation 
equilibria. For simultaneous determination of 
SMZ (a weak acid) and TMP (a weak base) 
using UV spectrophotometry, shifts caused by 
changes in pH can compromise the predictive 
ability of multivariate models. Hence, this body 
of work reports on the influence of pH on the 
predictive ability of multivariate models (PLS 
regression) for the simultaneous determination 
of SMZ-TMP using a UV spectrophotometric 
method. 
 
Experimental 
 
Chemicals 
 
Certified reference sulphamethoxazole 
(SMZ RS) and trimethoprim (TMP RS) 
materials were acquired from the Brazilian 
Pharmacopoeia (batches 1010 and 1011 for 
SMZ and TMP, respectively). The SMZ (batch 
22960805) and TMP (batch 200504246) bulk 
drugs were purchased from Henrifarma (Sao 
Paulo, Brazil) and were used for the preparation 
of synthetic samples. SMZ RS, TMP RS, SMZ 
bulk drug and TMP bulk drug showed purity in 
accordance with Brazilian Pharmacopoeia 
monographs (99-101% SMZ and 98.5-101% 
TMP). Methanol, acetonitrile and triethylamine 
were of HPLC grade. Thirteen commercial 
tablet formulations (named commercial 
samples) were acquired in local drugstores or 
were donated by pharmaceutical industries. 
Phosphate buffer (PB) solutions (pH 4.3-7.8) 
were prepared in accordance with the Brazilian 
Pharmacopoeia (2). 
 
Chromatographic system and conditions 
 
Determination of SMZ and TMP content 
was carried out using HPLC according to the 
method described in the United States 
Pharmacopoeia (3). This procedure was chosen 
as  the reference and it was performed with a 
HPLC system consisting of an Agilent 1100 
Series system equipped with a pump (model 
G1311A), a detector (model G1315B DAD) 
and an automatic sampling system (model 
G133A ALS). The detector was set at 254 nm 
and the peak areas were integrated 
automatically using a Chemstation® computer 
software program (Agilent Technologies Inc., 
California, USA). The separations were carried 
out at ambient temperature using a Zorbax® 
SBC-18 column (250 mm x 4.5 mm i.d., 5 µm 
particle size). A Zorbax® SBC-18 column (12.5 
mm x 4.5 mm i.d., 5 µm particle size) guard 
cartridge system was used to safeguard the 
analytical column. The mobile phase was a 
mixture of water: acetonitrile: triethylamine 
(1400:400:2, v/v/v). The pH was adjusted to 5.9 
and the volume (2000 mL) was completed with 
ultrapurified water. Commercial tablets were 
finely crushed to a fine powder and mixed. A 
mass corresponding to 160 mg of SMZ and 32 
mg TMP for each commercial formulation was 
accurately weighed and dissolved in 100 mL of 
methanol. Dissolution was carried out with the 
aid of an ultrasonic bath (15 min.) A 5 mL 
aliquot of each sample was added to 50 mL 
volumetric flasks and the mobile phase was 
used to complete the volume (SMZ work solution = 
160 µg mL-1; TMP work solution = 32 µg mL-1). All 
of analyses were performed in triplicate. 
 
Spectrophotometric system and conditions 
 
Spectrophotometric measurements were 
recording using a Shimadzu 1800 
spectrophotometer. All spectra were recorded 
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from 200 nm to 350 nm using quartz cuvettes 
with a 1 cm optical path. Thirty-six solutions 
containing SMZ-TMP were prepared in PB at 
each pH (4.3, 5.8, 6.6 and 7.8). From this series, 
22 solutions were chosen for the calibration set 
according to the mixture design for two 
component systems, and 14 solutions (chosen 
randomly) were used in the prediction set 
(Table 1). SMZ-TMP chemical species at 
different pKa values were calculated using 
MarvinSketch software, version 6.2.1 
(ChemAxon, USA). Commercial tablets were 
finely crushed to a fine powder and mixed. A 
mass corresponding to 100 mg of SMZ and 20 
mg of TMP for each commercial formulation 
was accurately weighed and dissolved in 100 
mL of methanol. Dissolution was carried out 
with the aid of an ultrasonic bath (15 min.) A 1 
mL aliquot of each sample was added to 50 mL 
volumetric flasks and PB at pH 4.3 was used to 
complete the volume (SMZ work solution = 20 µg 
mL-1; TMP work solution = 4 µg mL-1). All of 
analyses were performed in triplicate for both 
the synthetic and the commercial samples. 
 
Table 1 Calibration and prediction set for SMZ-TMP solutions. 
Samples SMZ (µg mL-1) TMP (µg mL-1) 
1 C 14.0 2.8 
2 C 15.5 2.8 
3 p 18.5 2.8 
4 C 21.5 2.8 
5 p 24.5 2.8 
6 C 26.0 2.8 
7 p 14.0 3.1 
8 p 15.5 3.1 
9 p 18.5 3.1 
10 p 21.5 3.1 
11 C 24.5 3.1 
12 p 26.0 3.1 
13 p 14.0 3.7 
14 C 15.5 3.7 
15 C 18.5 3.7 
16 C 21.5 3.7 
17 p 24.5 3.7 
18 C 26.0 3.7 
19 C 14.0 4.3 
20 C 15.5 4.3 
21 C 18.5 4.3 
22 C 21.5 4.3 
23 C 24.5 4.3 
24 C 26.0 4.3 
25 C 14.0 4.9 
26 p 15.5 4.9 
27 p 18.5 4.9 
28 p 21.5 4.9 
29 p 24.5 4.9 
30 C 26.0 4.9 
31 p 14.0 5.2 
32 C 15.5 5.2 
33 C 18.5 5.2 
34 C 21.5 5.2 
35 C 24.5 5.2 
36 p 26.0 5.2 
C Calibration, P Prediction 
 
Multivariate calibration 
 
Data were handled using Unscrambler X® 
software (CAMO, USA). The spectra of 
samples were preprocessed by multiplicative 
scatter correction (MSC), autoscalling (A) and 
mean centering (MC). A statistical F-test 
(α=0.5%) was introduced to evaluate if there 
were significant differences between the 
prediction errors of constructed models under 
different preprocessing conditions. PLS models 
were constructed at different pH values and the 
root mean squares error of cross-validation 
(RMSECV) was used to select the number of 
latent variables (LV). The root mean square 
error of calibration (RMSEC) and the root mean 
square error of prediction (RMSEP) were used 
to evaluate the prediction ability of different 
PLS models. The performance of the 
calibration models obtained was checked by the 
relative standard error of prediction (RSEP %) 
(8). The PLS model than presented the minor 
RMSEP value was selected for quantification 
of the commercial samples. 
 
Results and Discussion 
 
SMZ-TMP chemical species 
 
Theoretical values of pKa and chemical 
species were calculated from a 0 – 14 pH range 
in order to identify the protonation states of 
SMZ and TMP. SMZ (considered a weak acid) 
showed four ionized forms and one neutral 
form as presented in Figure 2 (4). 
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Figure 2 Chemical species of SMZ (A-E) in the 0–4 pH range (calculated by 
Marvin Sketch software). 
 
TMP (considered a weak base) showed 
three ionized forms and one neutral form as 
presented in Figure 3 (19). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Chemical species of TMP (A-D) in the 0–14 pH range (calculated by 
MarvinSketch software). 
 
Depending on the pH, chemical structures 
with protonatable groups may show shifts or 
alterations in signal intensity in UV spectra 
depending on the proximity of the ionizable 
groups and the chromophores (20). According 
to the data presented in table 2, the neutral form 
(D) of SMZ is predominant in solution prepared 
with pH 4.3 PB. For TMP, the ionized form (C) 
is predominant in solutions prepared with pH 
4.3 and pH 5.8 PB.  
 
 
 
 
 
 
 
Table 2 SMZ and TMP chemical species from pH 4.3–pH 7.8. 
 
 
 
 
SMZ-TMP spectrophotometric measurements 
 
 
 
 
 
 
 
 
 
 
 
 
According to the literature, the UV 
absorption spectra of SMZ show a lambda-max 
at 260 nm and TMP exhibits a UV lambda–max 
at 215 nm (7). In UV absorption spectra 
collected from a mixture containing SMZ-TMP 
(14 µg mL-1 and 2.8 µg mL-1, respectively), at 
different pH values, it is possible to observe 
shifts resulting from the ionization of the 
pharmaceuticals (Figure 4). At approximately 
260 nm hypsochromic and hiperchromic effects 
can be observed as the pH increases, which is 
typical for spectra of SMZ. The hypochromic 
effect at 215 nm (characteristic of TMP) was 
only observed for solutions prepared in pH 6.6 
and pH 7.8 PB. In solutions with lower pH 
values (4.3 and 5.8) lambda-max is shifted to 
values of less than 200 nm. This shift 
(hypsochromic effect) can be attributed to SMZ 
(in higher amount in SMZ-TMP solution). 
According to the literature, shifts can be 
observed in SMZ-TMP UV spectra acquired 
from solutions prepared in different conditions 
of acidity, requiring the use of buffer solutions 
(19). These shifts in SMZ-TMP spectra, caused 
by different acidic conditions, can interfere in 
UV spectrophotometric quantification, 
especially when information from a full 
spectrum or parts of a spectrum is used for 
constructing multivariate calibration models. 
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Figure 4 UV spectrum for SMZ-TMP solutions at different pH values. 
 
PLS regression models were developed for 
samples prepared under different pH conditions 
by using preprocessing AUTO. LV, RMSEC, 
RMSEP and Rcal² are shown in Table 3.  
 
Table 3 Statistical results of SMZ calibration models from 4.3–7.8 pH. 
pH LV* 
RMSEC  
(µg mL-1) 
RMSEP  
(µg mL-1) 
Rcal²** 
4.3 3 0.3997 0.3775 0.9915 
5.8 3 0.5237 0.4558 0.9855 
6.6 4 1.6802 1.1984 0.8550 
7.8 3 0.6665 0.7505 0.9763 
*LV: latent variables; **Rcal²: determination coefficient 
 
 
The SMZ PLS model with the lowest error 
was developed using pH 4.3 phosphate buffer 
solvent. Under these pH conditions, SMZ exists 
predominantly in its neutral form (D) and the 
PLS model was in good agreement with the 
reference values, i.e. the model showed good 
predicting ability (RSEP = 1.83%). Figure 5 
shows the reference values versus the predicted 
values for the calibration and validation sets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 SMZ reference values vs. SMZ predicted values for PLS model at pH 
4.3. 
 
 
Trimethoprim PLS models  
 
PLS regression models were developed for 
samples prepared under different pH conditions 
by using preprocessing AUTO. LV, RMSEC, 
RMSEP and Rcal² are shown in Table 4.  
 
Table 4 Statistical results of TMP calibration models from 4.3–5.8 pH. 
 
pH VL* 
RMSEC  
(µg mL-1) 
RMSEP  
(µg mL-1) 
Rcal²** 
4.3 4 0.0766 0.0462 0.9918 
5.8 4 0.1173 0.1335 0.9807 
6.6 5 0.2966 0.4294 0.8775 
7.8 5 0.1479 0.1379 0.9713 
*LV: latent variables; **Rcal²: determination coefficient. 
 
Similar to SMZ, the TMP PLS model with 
lowest error was developed using pH 4.3 
phosphate buffer solvent. Under these 
conditions, TMP predominantly exists in an 
ionized form (C) and the PLS model was in 
good agreement with the reference values, i.e. 
the model showed good predicting ability 
(RSEP = 1.13%). Figure 6 shows the reference 
values versus the predicted values for the 
calibration and the validation sets.  
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Figure 6 TMP reference values vs. TMP predicted values for PLS model at pH 
4.3. 
 
Sample analysis 
 
PLS models at pH 4.3 showed an Rcal² very 
close to the unity and the lowest RMSEC 
values, in respect to the models obtained for 
other pH values. At this pH, the TMP (in its 
ionized form, characteristic of weak bases) 
shows high signal intensity and SMZ (in its 
neutral form, characteristic of weak acids) 
shows weak signal intensity when observed in 
the full spectrum. These two related factors 
could explain why the model developed for this 
pH provides the minor comparative error. Table 
5 shows the recovery test for samples of the 
prediction set. The high recoveries recorded for 
the sample mixtures highlight the significant 
promise of the proposed method, in terms of the 
simultaneous determination of SMZ-TMP at 
pH 4.3. 
 
Table 5 Recovery test (%) of prediction set samples. 
 
The PLS models developed at pH 4.3 
were used for simultaneous SMZ-TMP 
quantification in real samples (tablets) 
from thirteen manufacturers and the values 
are shown in Table 6. Data were compared 
with values obtained from HPLC analysis. 
 
Table 6 SMZ-TMP prediction in real samples at pH 4.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The assay results (Table 6), expressed as 
the percentage of the label claim were found to 
be 94.10–104.50% for SMZ and 95.17–
106.80% for TMP. These results were in good 
agreement with the content of SMZ and TMP 
in the powder mixtures, according to the United 
States Pharmacopoeia requirements (93.00–
107.00%) for solid preparations (quantified by 
HPLC) (3). Satisfactory multivariate 
calibration models can be obtained when mean 
errors in concentrations between the reference 
and proposed methods lie in the ±5% to ±10% 
range, with values under ±2% proving ideal. 
This way, the assay results were compared 
using Two One-Side t Test (TOST) and twenty-
five (twelve samples for SMZ and thirteen 
samples for TMP) presented no significant 
differences at 95% confidence level. The only 
exception was between the result of HPLC 
versus UV for SMZ in real sample 3 (Table 6). 
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These results clearly show that the achievement 
of low prediction errors on real samples is 
possible as a consequence of the fact that the 
calibration set be representative of 
pharmaceutical formulation (quantitative 
composition of synthetic samples very similar 
to the real sample). For this sample 3, the 
quantitative compositions of the excipients 
present in the tablets may have influenced the 
results. 
 
Conclusions 
 
pH selection combined with multivariate 
calibration can be considered as a potential 
resource to be exploited in pharmaceutical 
powder mixture analysis. The pH selection used 
in this work produced models with high 
predictive ability, and demonstrated the need to 
further optimize the method with regards to UV 
analysis combined with multivariate 
calibration. Furthermore, proposed method 
showed high selectivity under the conditions 
tested, low cost and low production of toxic 
waste.  
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